Reply to comment on: Incidence and predictors of postoperative delirium after cytoreduction surgery-hyperthermic
Matthijs Plas1, Patrick H J Hemmer1, Lukas B Been1
1Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Journal of Surgical Oncology
|December 12, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
653
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
653
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
718
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
718

